5 Best Robotic Surgery Stocks to Buy

4. Globus Medical, Inc. (NYSE:GMED)

Number of Hedge Fund Holders: 42

Globus Medical, Inc. (NYSE:GMED) is one of the best robotic surgery stocks to buy. Wells Fargo cut the price target on Globus Medical, Inc. (NYSE:GMED) to $103 from $104 on May 8, maintaining an Overweight rating on the shares and noting that the company reported fiscal Q1 sales and EPS well ahead of its consensus and estimates.

In its financial results for fiscal Q1 2026, Globus Medical, Inc. (NYSE:GMED) reported worldwide net sales of $759.9 million, reflecting an increase of 27.0%, or an increase of 25.5% on a constant currency basis. Management further reported that base business, excluding Nevro, net sales were $677.2 million, up 13.2%, or an increase of 11.2% on a constant currency basis. The company headed off a strong start to the year, with record Q1 earnings and organic revenue growth driven by share gains and procedural volume strength in core spine. Keith Pfeil, President and Chief Executive Officer, also stated that Enabling Technologies delivered against its pipeline and continued to expand the company’s customer base.

Globus Medical, Inc. (NYSE:GMED) is a medical device company involved in the development and commercialization of healthcare solutions. The company classifies its products into Innovative Fusion and Disruptive Technology, and operates through the United States and International geographical segments.